and hypotheses both submitted spontaneously and invited. The keynote will be interdisciplinary crossfertilization.
This first volume leans rather heavily towards acute nonlymphocytic leukaemia and this is reasonable since, although relatively rare, this group of diseases has proved therapeutically intractable. The topics include colony production, human B lymphocyte antigens, chromosome aberrations and prognosis, the heterogeneity of human leukaemic cell lines, the use of bone marrow transplantation, chemotherapy and an excellent review of acute granulocytic leukaemia by Gunz & Vincent.
The editors are from Copenhagen and the consultant editors are Jean Bernard and Eugene P Cronkite, with an equally distinguished editorial board. This journal deserves our best wishes for a successful future even though one hopes that the need for such a journal will eventually disappear with the development of 'curative' treatment for leukaemia.
R HARRIS

Director Department of Medical Genetics
University of Manchester This impressive volume of twenty-six chapters by twenty-four authors offers a series of reviews up to 1975, with some work from 1976, on the physiology and pathology of haemostasis. The management of haemostatic disorders is purposely excluded as being adequately covered elsewhere; and the editors acknowledge omission of formal discussion on prothrombin, DIC and platelet pathology. Otherwise, the coverage is comprehensive and the topics are dealt with in detail and at an advanced level with extensive citation. The approach is predominantly biochemical; and the major emphasis is in the fields of fibrinogen, plasminogen, their interaction and derivatives and related matters; here the book is encyclopaedic. In addition, there are wide ranging reviews of haemostasis; and a number of chapters by several contributors are devoted to platelets, factors V, VIII and the K-dependent factors, which will be of value to many workers.
There is a good index, and section headings are listed at the beginning of each chapter; but rapid reference is somewhat impeded by the lack of running heads either of author or chapter title, so that one does not immediately know where the book has been opened. A striking feature is the scatter of short chapters (often by the editors) neatly plugging small gaps between the major contributions. The editors are to be congratulated both on their perception of the range of subjects to be covered and on the cohesion of the whole book. 'Haemostasis' is likely to remain a major source of information on published work, especially for the decade 1965-75, and can be warmly recommended. GI Clinical aspects are dealt with in the final eight papers, and there is a small section on bile composition. Although this book will appeal predominantly to the biochemist and chemical pathologist, it will also prove useful to others seeking a reference source to recent work rather than a comprehensive review.
DE M TAYLOR
Professor of Applied Physiology & Surgical Science, University ofLondon
Clinical Oncology. John Horton & George J Hill II (eds) pp 836 £19.50 Saunders 1977 This is an American multi-author book written for medical students, interns and residents. It covers the general principles of tumour growth. spread effect and diagnosis, and the methods by which tumours are treated, including surgery, radiotherapy and chemotherapy. Tumours at individual sites are then considered, with details of their management.
The book does not give enough detailed information for the specialist but it is a useful introductory book for those beginning a training in oncology. It is profusely illustrated with anatomical drawings, pictures of pathological specimens and illustrations of surgical procedures. There are tables of suggested guidelines for the follow up of patients. Each chapter has numerous references and there is a comprehensive index.
Some of the treatment schemes are not those usualIy. followed in the United Kingdom, for exa~ple retroperitoneal lymph node dissection in testlul ar tumours is not generally used.
R~dlotherapy
for skin malignancy is not usually rejected on account of its higher cost!
